about
REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapyAntigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstemTumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model.Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo.Mesenchymal stem cells engineered for cancer therapyDendritic cell-based immunotherapy for malignant gliomas.Genetic strategies for brain tumor therapy.Tumor immunology, immunomics and targeted immunotherapy for central nervous system malignancies.Current immunotherapeutic strategies for central nervous system tumors.Cell therapies for glioblastoma.Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications.Ependymomas: development of immunotherapeutic strategies.Engineering antiphagocytic biomimetic drug carriers.Stem cell-based therapies for tumors in the brain: are we there yet?Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study.[Janus-faced?: Effects and side-effects of interferon therapy in ophthalmology].
P2860
Q33574535-330FF979-5267-49A0-A558-FD95B95A7E2AQ33796170-E2012783-EB54-484D-99C5-B89597E55C8FQ33903144-A228814F-7157-4EBF-BC77-B3D9D599244CQ35127438-DE271BE4-5120-4C0A-B468-D38619F0B8CFQ36092724-80FDF0AA-C3D4-42CD-855A-42CD58867E78Q36198607-8EF1E8BB-EF60-447F-9EF7-38F4B5B889BAQ36247099-9962B546-17DA-4AE4-B463-F8D841C3C0B1Q36273691-BEFEB9F2-4605-4521-83EA-B39A19F207C0Q36325239-BC98AC12-FF2F-4B50-8361-F230BF0D9F25Q36541937-18D22191-9E58-4968-881A-CEEA70F0708BQ36641509-3F85A4B8-6EEB-4FCF-A8F7-AE9A8665E197Q37678294-8F914D8C-56ED-44A0-9A7F-0D7855E00B38Q38123856-9806194B-535C-44C1-B2A6-CDF859146801Q38855638-C887F59E-B815-4B5A-AA6F-58B8D23D6D5CQ45933704-5A3C8010-016C-4ED6-8C96-84A7463A99B4Q52897774-D0B6FC56-7DF5-4BFE-828D-7B051D3B7CB0
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Cytokine gene therapy for malignant glioma.
@ast
Cytokine gene therapy for malignant glioma.
@en
type
label
Cytokine gene therapy for malignant glioma.
@ast
Cytokine gene therapy for malignant glioma.
@en
prefLabel
Cytokine gene therapy for malignant glioma.
@ast
Cytokine gene therapy for malignant glioma.
@en
P2860
P1476
Cytokine gene therapy for malignant glioma.
@en
P2093
Hideho Okada
Ian F Pollack
P2860
P304
P356
10.1517/14712598.4.10.1609
P407
P577
2004-10-01T00:00:00Z